Mylan Board rejects unsolicited Teva proposal
MLex Summary: Generic drugmaker Mylan has said Monday that its board of directors has unanimously rejected an unsolicited takeover bid from industry rival Teva Pharmaceutical Industries. The offer “grossly undervalues” the company, says a...To view the full article, register now.
Already a subscriber? Click here to view full article